Molecular characterization of T cell receptor beta variable in the peripheral blood T cell repertoire in subjects with active tuberculosis or latent tuberculosis infection

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Yang, Jiezuan ^a,b   He, Jianqin ^a,b   Huang, Haijun ^a,b,c   Ji, Zhongkang ^a,b   Wei, Li ^a,b   Ye, Ping ^a,b   Xu, Kaijin ^a,b   Li, Lanjuan ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

AMINO ACID SEQUENCE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; GENE MELTING SPECTRAL PATTERN ASSAY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LATENT TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TUBERCULOSIS;

ADULT; AMINO ACID MOTIFS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENETIC VARIATION; HUMANS; LATENT TUBERCULOSIS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TUBERCULOSIS; YOUNG ADULT;

EID: 84883527527     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-423     Document Type: Article

References (51)

1. Organization WH WHO Global Tuberculosis Report 2010 2010, Geneva Swiss: WHO, Organization WH.
2. Wilson ML. Recent advances in the laboratory detection of mycobacterium tuberculosis complex and drug resistance. Clin Infect Dis 2011, 52(11):1350-1355. 10.1093/cid/cir146, 21596676.
3. Richeldi L, Losi M, Cerri S, Casali L, Fabbri LM, Ferrara G. Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay. Expert Rev Respir Med 2008, 2(2):253-260. 10.1586/17476348.2.2.253, 20477253.
4. Kim SH, Song KH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009, 122(2):189-195. 10.1016/j.amjmed.2008.07.028, 19185094.
5. Lesho E, Forestiero FJ, Hirata MH, Hirata RD, Cecon L, Melo FF, Paik SH, Murata Y, Ferguson EW, Wang Z, et al. Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis 2011, 91(5):390-399. 10.1016/j.tube.2011.07.002, 21835698.
6. Marin ND, Paris SC, Rojas M, Garcia LF. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. Tuberculosis 2013, 93(2):155-166. 10.1016/j.tube.2012.12.002, 23332142.
7. Brodie D, Lederer DJ, Gallardo JS, Trivedi SH, Burzynski JN, Schluger NW. Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients. Chest 2008, 133(4):869-874. 10.1378/chest.07-1815, 18198254.
8. Lange C, Pai M, Drobniewski F, Migliori GB. Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly?. Eur Respir J 2009, 33(6):1250-1253. 10.1183/09031936.00019709, 19483044.
9. Qiu Z, Zhang M, Zhu Y, Zheng F, Lu P, Liu H, Graner MW, Zhou B, Chen X. Multifunctional CD4 T cell responses in patients with active tuberculosis. Sci Rep 2012, 2:216. 3253855, 22355730.
10. Hodapp T, Sester U, Mack U, Singh M, Meier T, Wiech E, Fisch P, Ehl S, Sester M. Massive monoclonal expansion of CD4 T-cells specific for a M. tuberculosis ESAT-6 peptide. Eur Respir J 2012, 40(1):152-160. 10.1183/09031936.00175611, 22267771.
11. Adekambi T, Ibegbu CC, Kalokhe AS, Yu T, Ray SM, Rengarajan J. Distinct effector memory CD4(+) T cell signatures in latent mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis. PLoS One 2012, 7(4):e36046. 10.1371/journal.pone.0036046, 3335801, 22545156.
12. Qiao D, Li L, Guo J, Lao S, Zhang X, Zhang J, Wu C. Mycobacterium tuberculosis culture filtrate protein 10-specific effector/memory CD4 and CD8 T cells in tubercular pleural fluid, with biased usage of T cell receptor Vbeta chains. Infect Immun 2011, 79(8):3358-3365. 10.1128/IAI.00014-11, 3147558, 21606188.
13. Tully G, Kortsik C, Hohn H, Zehbe I, Hitzler WE, Neukirch C, Freitag K, Kayser K, Maeurer MJ. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J Immunol 2005, 174(4):2174-2184.
14. Yang JZ, Li MW, Wang JG, Lu HF, Yao XS, He JQ, Li LJ. Rapid detection of clonal expansion of T-cell receptor-beta gene in patients with HBV using the real-time PCR with DNA melting curve analysis. Hepatol Res 2010, 40(4):407-414. 10.1111/j.1872-034X.2009.00600.x, 20070405.
15. Yang J, He J, Lu H, Wei L, Li S, Wang B, Diao H, Li L. Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B. J Transl Med 2011, 9(1):210. 10.1186/1479-5876-9-210, 3256121, 22152113.
16. Ochsenreither S, Fusi A, Busse A, Nagorsen D, Schrama D, Becker J, Thiel E, Keilholz U. Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations. J Transl Med 2008, 6:34. 10.1186/1479-5876-6-34, 2467404, 18593466.
17. Sun W, Nie H, Li N, Zang YC, Zhang D, Feng G, Ni L, Xu R, Prasad S, Robinson RR, et al. Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis. Genes Immun 2005, 6(3):248-261. 10.1038/sj.gene.6364166, 15674392.
18. Sing GK, Li D, Chen X, Macnaughton T, Lichanska AM, Butterworth L, Ladhams A, Cooksley G. A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B: evidence for antigen-driven selection of a public complementarity-determining region 3 (CDR3) motif. Hepatology 2001, 33(5):1288-1298. 10.1053/jhep.2001.24026, 11343258.
19. Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 2004, 364(9431):355-364. 10.1016/S0140-6736(04)16724-X, 15276395.
20. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007, 196(Suppl 1):S86-107.
21. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009, 27:393-422. 10.1146/annurev.immunol.021908.132703, 19302046.
22. Ciuffreda D, Comte D, Cavassini M, Giostra E, Buhler L, Perruchoud M, Heim MH, Battegay M, Genne D, Mulhaupt B, et al. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 2008, 38(10):2665-2677. 10.1002/eji.200838336, 18958874.
23. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007, 13(7):843-850. 10.1038/nm1592, 17558415.
24. Du G, Chen CY, Shen Y, Qiu L, Huang D, Wang R, Chen ZW. TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis. J Immunol 2010, 185(7):3940-3947. 10.4049/jimmunol.1001222, 3586329, 20805423.
25. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996, 274(5285):209-219. 10.1126/science.274.5285.209, 8824178.
26. Leimgruber A, Ferber M, Irving M, Hussain-Kahn H, Wieckowski S, Derre L, Rufer N, Zoete V, Michielin O. TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires. PLoS One 2011, 6(10):e26301. 10.1371/journal.pone.0026301, 3203878, 22053188.
27. Marrack P, Kappler J. Positive selection of thymocytes bearing alpha beta T cell receptors. Curr Opin Immunol 1997, 9(2):250-255. 10.1016/S0952-7915(97)80144-6, 9099796.
28. Miqueu P, Guillet M, Degauque N, Dore JC, Soulillou JP, Brouard S. Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases. Mol Immunol 2007, 44(6):1057-1064. 10.1016/j.molimm.2006.06.026, 16930714.
29. Sabet S, Ochoa MT, Sieling PA, Rea TH, Modlin RL. Functional characterization of a T-cell receptor BV6+ T-cell clone derived from a leprosy lesion. Immunology 2007, 120(3):354-361. 10.1111/j.1365-2567.2006.02510.x, 2265884, 17140401.
30. Miles JJ, Douek DC, Price DA. Bias in the alphabeta T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol 2011, 89(3):375-387. 10.1038/icb.2010.139, 21301479.
31. Wang GC, Dash P, McCullers JA, Doherty PC, Thomas PG. T cell receptor alphabeta diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection. Sci Transl Med 2012, 4(128):128ra-142.
32. Vigano S, Bellutti Enders F, Miconnet I, Cellerai C, Savoye AL, Rozot V, Perreau M, Faouzi M, Ohmiti K, Cavassini M, et al. Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells. PLoS Pathog 2013, 9(7):e1003423. 10.1371/journal.ppat.1003423, 3701695, 23853580.
33. Klarenbeek PL, Remmerswaal EB, Ten Berge IJ, Doorenspleet ME, Van Schaik BD, Esveldt RE, Koch SD, Ten Brinke A, Van Kampen AH, Bemelman FJ, et al. Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS Pathog 2012, 8(9):e1002889. 10.1371/journal.ppat.1002889, 3460621, 23028307.
34. Naumov YN, Naumova EN, Yassai MB, Kota K, Welsh RM, Selin LK. Multiple glycines in TCR alpha-chains determine clonally diverse nature of human T cell memory to influenza A virus. J Immunol 2008, 181(10):7407-7419. 2646260, 18981164.
35. Yang J, Chen J, Mao H, Yi P, Yan D, He J, Li L. Skewed T-cell receptor beta chain variable gene (TCRBV) usage among different clinical types of patients with chronic HBV infection. FEMS Immunol Med Microbiol 2012, 65(3):448-455. 10.1111/j.1574-695X.2012.00969.x, 22469337.
36. Turner SJ, La Gruta NL, Kedzierska K, Thomas PG, Doherty PC. Functional implications of T cell receptor diversity. Curr Opin Immunol 2009, 21(3):286-290. 10.1016/j.coi.2009.05.004, 2706259, 19524428.
37. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L, Galati D, Bocchino M, Matarese A, Salerno A, et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010, 40(8):2211-2220. 10.1002/eji.201040455, 20540114.
38. Hessmann M, Rausch A, Ruckerl D, Adams PS, Simon M, Gilfillan S, Colonna M, Ehlers S, Holscher C. DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during mycobacterium tuberculosis infection. Immunobiology 2011, 216(5):639-647. 10.1016/j.imbio.2010.09.010, 21122940.
39. Caccamo N, Guggino G, Meraviglia S, Gelsomino G, Di Carlo P, Titone L, Bocchino M, Galati D, Matarese A, Nouta J, et al. Analysis of mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection. PLoS One 2009, 4(5):e5528. 10.1371/journal.pone.0005528, 2678250, 19436760.
40. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, Pasvol G, Hill AV. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001, 163(4):824-828. 10.1164/ajrccm.163.4.2009100, 11282752.
41. Sester U, Fousse M, Dirks J, Mack U, Prasse A, Singh M, Lalvani A, Sester M. Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS One 2011, 6(3):e17813. 10.1371/journal.pone.0017813, 3058054, 21423578.
42. Nemeth J, Winkler HM, Zwick RH, Muller C, Rumetshofer R, Boeck L, Burghuber OC, Winkler S. Peripheral T cell cytokine responses for diagnosis of active tuberculosis. PLoS One 2012, 7(4):e35290. 10.1371/journal.pone.0035290, 3327656, 22523581.
43. Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, Bua A, Molicotti P, Zanetti S, Lauria FN, Grisetti S. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS One 2011, 6(3):e18315. 10.1371/journal.pone.0018315, 3066236, 21479248.
44. Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, et al. Genetic engineering of murine CD8(+) and CD4(+) T cells for preclinical adoptive immunotherapy studies. J Immunother 2011, 34(4):343-352. 10.1097/CJI.0b013e3182187600, 3100770, 21499127.
45. Bendle GM, Haanen JB, Schumacher TN. Preclinical development of T cell receptor gene therapy. Curr Opin Immunol 2009, 21(2):209-214. 10.1016/j.coi.2009.02.007, 19321326.
46. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006, 314(5796):126-129. 10.1126/science.1129003, 2267026, 16946036.
47. Spranger S, Jeremias I, Wilde S, Leisegang M, Starck L, Mosetter B, Uckert W, Heemskerk MH, Schendel DJ, Frankenberger B. TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo. Blood 2012, 119(15):3440-3449. 10.1182/blood-2011-06-357939, 22371883.
48. Linnemann C, Schumacher TN, Bendle GM. T-cell receptor gene therapy: critical parameters for clinical success. J Invest Dermatol 2011, 131(9):1806-1816. 10.1038/jid.2011.160, 21677669.
49. Luo W, Zhang XB, Huang YT, Hao PP, Jiang ZM, Wen Q, Zhou MQ, Jin Q, Ma L. Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen. J Mol Med (Berl) 2011, 89(9):903-913.
50. Jorritsma A, Schotte R, Coccoris M, De Witte MA, Schumacher TN. Prospects and limitations of T cell receptor gene therapy. Curr Gene Ther 2011, 11(4):276-287. 10.2174/156652311796150390, 21453279.
51. Axelsson-Robertson R, Magalhaes I, Parida SK, Zumla A, Maeurer M. The immunological footprint of Mycobacterium tuberculosis T-cell epitope recognition. J Infect Dis 2012, 205(Suppl 2):S301-315. 10.1093/infdis/jis198, 22448020.